| Srl | Item |
| 1 |
ID:
165226
|
|
|
| 2 |
ID:
169964
|
|
|
|
|
| Summary/Abstract |
Mounting import competition from China has increased unemployment in manufacturing and suppressed wages in local labor markets around the United States. This article investigates the political effects of this China trade shock, using a unique dataset of the district-level economic impact of Chinese imports to the United States. The liberalization of trade following China’s accession to the World Trade Organization increased political polarization among American voters and encouraged legislators in economically hard-hit districts to take positions hostile to China. The result is that Congress is even more hostile towards China today than in the aftermath of the Tiananmen Massacre. After 2003, members of Congress who voted against China were more likely to come from districts that were adversely impacted by import competition, controlling for ideology and partisanship. By contrast, import competition was not a significant predictor of earlier congressional opposition to granting most-favored-nation status to China (suggesting that voting on these crucial pieces of legislation was driven by non-economic concerns such as human rights). Far from being the political win–win its proponents envisioned, trade has eclipsed human rights and Taiwan as the main driver of hostility to China in Congress.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3 |
ID:
177655
|
|
|
|
|
| Summary/Abstract |
US-China health cooperation reaches back to the signing of
the bilateral Science and Technology Umbrella Agreement,
their first agreement after normalization of diplomatic relations in 1979. Bilateral cooperation has shaped the China
Center for Disease Control and Prevention (China CDC) and
produced some of the world’s finest epidemiological research over the last thirty years. US-China research and technical cooperation has covered the full range of health-related topics, with no area given more attention than research
and technical cooperation on emerging infectious diseases. In the wake of the outbreak of severe acute respiratory syndrome (SARS), the United States ramped up the staff
presence of its Center for Disease Control (CDC) in China.
Although this changed in the Obama years, as China’s epidemiological capacity developed rapidly, the dramatic shift
occurred with the Trump administration, whose cuts, just as
COVID-19 arose as the largest epidemiological threat to the
world in a century, left only a skeleton staff in place, and the
US government without eyes and ears on the ground. Nonetheless, there is a reservoir of mutual respect and willingness
to cooperate among the health professionals in both countries. If there is political will, this could become the foundation for a next-phase bilateral health relationship.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|